ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Migraine Drugs Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-25T2055
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Migraine Drugs Market Insights Forecast to 2028
BUY CHAPTERS

Global Migraine Drugs Market Research Report 2025

Code: QYRE-Auto-25T2055
Report
January 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Allergan plc
Merck
TEVA
Johnson & Johnson
Endo International
GlaxoSmithKline PLC
Impax
Abbott
Bayer
Eli Lilly
Ethypharm
Kowa Pharmaceuticals America
Winston Pharmaceuticals
Astrazeneca plc
Pfizer Inc

Migraine Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Migraine Drugs Market

Migraine Drugs Market

The global market for Migraine Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Migraine Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Migraine Drugs.
The Migraine Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Migraine Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Migraine Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Migraine Drugs Market Report

Report Metric Details
Report Name Migraine Drugs Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Household Use
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Allergan, Merck, Pfizer, Teva, Johnson & Johnson, Endo International, GlaxoSmithKline, Impax, Abbott, Bayer, Eli Lilly, Ethypharm, Kowa Pharmaceuticals America, Winston Pharmaceuticals, AstraZeneca
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Migraine Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Migraine Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Migraine Drugs Market report?

Ans: The main players in the Migraine Drugs Market are Allergan, Merck, Pfizer, Teva, Johnson & Johnson, Endo International, GlaxoSmithKline, Impax, Abbott, Bayer, Eli Lilly, Ethypharm, Kowa Pharmaceuticals America, Winston Pharmaceuticals, AstraZeneca

What are the Application segmentation covered in the Migraine Drugs Market report?

Ans: The Applications covered in the Migraine Drugs Market report are Hospitals, Clinics, Household Use, Others

What are the Type segmentation covered in the Migraine Drugs Market report?

Ans: The Types covered in the Migraine Drugs Market report are Sumatriptan, Zolmitriptan, Rizatriptan, Others Drug

Recommended Reports

Pain & Neurology Drugs

Central Nervous Drugs

Drug Delivery & Management

1 Migraine Drugs Market Overview
1.1 Product Definition
1.2 Migraine Drugs by Type
1.2.1 Global Migraine Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sumatriptan
1.2.3 Zolmitriptan
1.2.4 Rizatriptan
1.2.5 Others Drug
1.3 Migraine Drugs by Application
1.3.1 Global Migraine Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Household Use
1.3.5 Others
1.4 Global Migraine Drugs Market Size Estimates and Forecasts
1.4.1 Global Migraine Drugs Revenue 2020-2031
1.4.2 Global Migraine Drugs Sales 2020-2031
1.4.3 Global Migraine Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Migraine Drugs Market Competition by Manufacturers
2.1 Global Migraine Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Migraine Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Migraine Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Migraine Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Migraine Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Migraine Drugs, Product Type & Application
2.7 Global Key Manufacturers of Migraine Drugs, Date of Enter into This Industry
2.8 Global Migraine Drugs Market Competitive Situation and Trends
2.8.1 Global Migraine Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Migraine Drugs Players Market Share by Revenue
2.8.3 Global Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Migraine Drugs Market Scenario by Region
3.1 Global Migraine Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Migraine Drugs Sales by Region: 2020-2031
3.2.1 Global Migraine Drugs Sales by Region: 2020-2025
3.2.2 Global Migraine Drugs Sales by Region: 2026-2031
3.3 Global Migraine Drugs Revenue by Region: 2020-2031
3.3.1 Global Migraine Drugs Revenue by Region: 2020-2025
3.3.2 Global Migraine Drugs Revenue by Region: 2026-2031
3.4 North America Migraine Drugs Market Facts & Figures by Country
3.4.1 North America Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Migraine Drugs Sales by Country (2020-2031)
3.4.3 North America Migraine Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Migraine Drugs Market Facts & Figures by Country
3.5.1 Europe Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Migraine Drugs Sales by Country (2020-2031)
3.5.3 Europe Migraine Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Migraine Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Migraine Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Migraine Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Migraine Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Migraine Drugs Market Facts & Figures by Country
3.7.1 Latin America Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Migraine Drugs Sales by Country (2020-2031)
3.7.3 Latin America Migraine Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Migraine Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Migraine Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Migraine Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Migraine Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Migraine Drugs Sales by Type (2020-2031)
4.1.1 Global Migraine Drugs Sales by Type (2020-2025)
4.1.2 Global Migraine Drugs Sales by Type (2026-2031)
4.1.3 Global Migraine Drugs Sales Market Share by Type (2020-2031)
4.2 Global Migraine Drugs Revenue by Type (2020-2031)
4.2.1 Global Migraine Drugs Revenue by Type (2020-2025)
4.2.2 Global Migraine Drugs Revenue by Type (2026-2031)
4.2.3 Global Migraine Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Migraine Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Migraine Drugs Sales by Application (2020-2031)
5.1.1 Global Migraine Drugs Sales by Application (2020-2025)
5.1.2 Global Migraine Drugs Sales by Application (2026-2031)
5.1.3 Global Migraine Drugs Sales Market Share by Application (2020-2031)
5.2 Global Migraine Drugs Revenue by Application (2020-2031)
5.2.1 Global Migraine Drugs Revenue by Application (2020-2025)
5.2.2 Global Migraine Drugs Revenue by Application (2026-2031)
5.2.3 Global Migraine Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Migraine Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Company Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Allergan Migraine Drugs Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Migraine Drugs Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Migraine Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Teva
6.4.1 Teva Company Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Migraine Drugs Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Migraine Drugs Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Johnson & Johnson Migraine Drugs Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Endo International
6.7.1 Endo International Company Information
6.7.2 Endo International Description and Business Overview
6.7.3 Endo International Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Endo International Migraine Drugs Product Portfolio
6.7.5 Endo International Recent Developments/Updates
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Company Information
6.8.2 GlaxoSmithKline Description and Business Overview
6.8.3 GlaxoSmithKline Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 GlaxoSmithKline Migraine Drugs Product Portfolio
6.8.5 GlaxoSmithKline Recent Developments/Updates
6.9 Impax
6.9.1 Impax Company Information
6.9.2 Impax Description and Business Overview
6.9.3 Impax Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Impax Migraine Drugs Product Portfolio
6.9.5 Impax Recent Developments/Updates
6.10 Abbott
6.10.1 Abbott Company Information
6.10.2 Abbott Description and Business Overview
6.10.3 Abbott Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Abbott Migraine Drugs Product Portfolio
6.10.5 Abbott Recent Developments/Updates
6.11 Bayer
6.11.1 Bayer Company Information
6.11.2 Bayer Description and Business Overview
6.11.3 Bayer Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Bayer Migraine Drugs Product Portfolio
6.11.5 Bayer Recent Developments/Updates
6.12 Eli Lilly
6.12.1 Eli Lilly Company Information
6.12.2 Eli Lilly Description and Business Overview
6.12.3 Eli Lilly Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Eli Lilly Migraine Drugs Product Portfolio
6.12.5 Eli Lilly Recent Developments/Updates
6.13 Ethypharm
6.13.1 Ethypharm Company Information
6.13.2 Ethypharm Description and Business Overview
6.13.3 Ethypharm Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Ethypharm Migraine Drugs Product Portfolio
6.13.5 Ethypharm Recent Developments/Updates
6.14 Kowa Pharmaceuticals America
6.14.1 Kowa Pharmaceuticals America Company Information
6.14.2 Kowa Pharmaceuticals America Description and Business Overview
6.14.3 Kowa Pharmaceuticals America Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Kowa Pharmaceuticals America Migraine Drugs Product Portfolio
6.14.5 Kowa Pharmaceuticals America Recent Developments/Updates
6.15 Winston Pharmaceuticals
6.15.1 Winston Pharmaceuticals Company Information
6.15.2 Winston Pharmaceuticals Description and Business Overview
6.15.3 Winston Pharmaceuticals Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Winston Pharmaceuticals Migraine Drugs Product Portfolio
6.15.5 Winston Pharmaceuticals Recent Developments/Updates
6.16 AstraZeneca
6.16.1 AstraZeneca Company Information
6.16.2 AstraZeneca Description and Business Overview
6.16.3 AstraZeneca Migraine Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 AstraZeneca Migraine Drugs Product Portfolio
6.16.5 AstraZeneca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Migraine Drugs Industry Chain Analysis
7.2 Migraine Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Migraine Drugs Production Mode & Process Analysis
7.4 Migraine Drugs Sales and Marketing
7.4.1 Migraine Drugs Sales Channels
7.4.2 Migraine Drugs Distributors
7.5 Migraine Drugs Customer Analysis
8 Migraine Drugs Market Dynamics
8.1 Migraine Drugs Industry Trends
8.2 Migraine Drugs Market Drivers
8.3 Migraine Drugs Market Challenges
8.4 Migraine Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Allergan plc
Merck
TEVA
Johnson & Johnson
Endo International
GlaxoSmithKline PLC
Impax
Abbott
Bayer
Eli Lilly
Ethypharm
Kowa Pharmaceuticals America
Winston Pharmaceuticals
Astrazeneca plc
Pfizer Inc
List of Tables
 Table 1. Global Migraine Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Migraine Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Migraine Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Migraine Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Migraine Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Migraine Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Migraine Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Migraine Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Migraine Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Migraine Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Migraine Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Migraine Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Migraine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Migraine Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Migraine Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Migraine Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Migraine Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Migraine Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Migraine Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Migraine Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Migraine Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Migraine Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Migraine Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Migraine Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Migraine Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Migraine Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Migraine Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Migraine Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Migraine Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Migraine Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Migraine Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Migraine Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Migraine Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Migraine Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Migraine Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Migraine Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Migraine Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Migraine Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Migraine Drugs Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Migraine Drugs Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Migraine Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Migraine Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Migraine Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Migraine Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Migraine Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Migraine Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Migraine Drugs Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Migraine Drugs Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Migraine Drugs Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Migraine Drugs Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Migraine Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Migraine Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Migraine Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Migraine Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Migraine Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Migraine Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Migraine Drugs Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Migraine Drugs Price (USD/Pcs) by Application (2026-2031)
 Table 70. Allergan Company Information
 Table 71. Allergan Description and Business Overview
 Table 72. Allergan Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Allergan Migraine Drugs Product
 Table 74. Allergan Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Merck Migraine Drugs Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Pfizer Migraine Drugs Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Teva Company Information
 Table 86. Teva Description and Business Overview
 Table 87. Teva Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Teva Migraine Drugs Product
 Table 89. Teva Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Pfizer Migraine Drugs Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. Johnson & Johnson Company Information
 Table 96. Johnson & Johnson Description and Business Overview
 Table 97. Johnson & Johnson Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Johnson & Johnson Migraine Drugs Product
 Table 99. Johnson & Johnson Recent Developments/Updates
 Table 100. Endo International Company Information
 Table 101. Endo International Description and Business Overview
 Table 102. Endo International Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Endo International Migraine Drugs Product
 Table 104. Endo International Recent Developments/Updates
 Table 105. GlaxoSmithKline Company Information
 Table 106. GlaxoSmithKline Description and Business Overview
 Table 107. GlaxoSmithKline Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. GlaxoSmithKline Migraine Drugs Product
 Table 109. GlaxoSmithKline Recent Developments/Updates
 Table 110. Impax Company Information
 Table 111. Impax Description and Business Overview
 Table 112. Impax Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Impax Migraine Drugs Product
 Table 114. Impax Recent Developments/Updates
 Table 115. Abbott Company Information
 Table 116. Abbott Description and Business Overview
 Table 117. Abbott Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Abbott Migraine Drugs Product
 Table 119. Abbott Recent Developments/Updates
 Table 120. Bayer Company Information
 Table 121. Bayer Description and Business Overview
 Table 122. Bayer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Bayer Migraine Drugs Product
 Table 124. Bayer Recent Developments/Updates
 Table 125. Eli Lilly Company Information
 Table 126. Eli Lilly Description and Business Overview
 Table 127. Eli Lilly Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Eli Lilly Migraine Drugs Product
 Table 129. Eli Lilly Recent Developments/Updates
 Table 130. Ethypharm Company Information
 Table 131. Ethypharm Description and Business Overview
 Table 132. Ethypharm Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Ethypharm Migraine Drugs Product
 Table 134. Ethypharm Recent Developments/Updates
 Table 135. Kowa Pharmaceuticals America Company Information
 Table 136. Kowa Pharmaceuticals America Description and Business Overview
 Table 137. Kowa Pharmaceuticals America Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. Kowa Pharmaceuticals America Migraine Drugs Product
 Table 139. Kowa Pharmaceuticals America Recent Developments/Updates
 Table 140. Winston Pharmaceuticals Company Information
 Table 141. Winston Pharmaceuticals Description and Business Overview
 Table 142. Winston Pharmaceuticals Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 143. Winston Pharmaceuticals Migraine Drugs Product
 Table 144. Winston Pharmaceuticals Recent Developments/Updates
 Table 145. AstraZeneca Company Information
 Table 146. AstraZeneca Description and Business Overview
 Table 147. AstraZeneca Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 148. AstraZeneca Migraine Drugs Product
 Table 149. AstraZeneca Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Migraine Drugs Distributors List
 Table 153. Migraine Drugs Customers List
 Table 154. Migraine Drugs Market Trends
 Table 155. Migraine Drugs Market Drivers
 Table 156. Migraine Drugs Market Challenges
 Table 157. Migraine Drugs Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Migraine Drugs
 Figure 2. Global Migraine Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Migraine Drugs Market Share by Type: 2024 & 2031
 Figure 4. Sumatriptan Product Picture
 Figure 5. Zolmitriptan Product Picture
 Figure 6. Rizatriptan Product Picture
 Figure 7. Others Drug Product Picture
 Figure 8. Global Migraine Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Migraine Drugs Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Clinics
 Figure 12. Household Use
 Figure 13. Others
 Figure 14. Global Migraine Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Migraine Drugs Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Migraine Drugs Sales (2020-2031) & (K Pcs)
 Figure 17. Global Migraine Drugs Average Price (USD/Pcs) & (2020-2031)
 Figure 18. Migraine Drugs Report Years Considered
 Figure 19. Migraine Drugs Sales Share by Manufacturers in 2024
 Figure 20. Global Migraine Drugs Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Migraine Drugs Players: Market Share by Revenue in Migraine Drugs in 2024
 Figure 22. Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Migraine Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Migraine Drugs Sales Market Share by Country (2020-2031)
 Figure 25. North America Migraine Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Migraine Drugs Sales Market Share by Country (2020-2031)
 Figure 29. Europe Migraine Drugs Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Migraine Drugs Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Migraine Drugs Revenue Market Share by Region (2020-2031)
 Figure 37. China Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Migraine Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Migraine Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Migraine Drugs Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Migraine Drugs Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Migraine Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Migraine Drugs by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Migraine Drugs by Type (2020-2031)
 Figure 59. Global Migraine Drugs Price (USD/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Migraine Drugs by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Migraine Drugs by Application (2020-2031)
 Figure 62. Global Migraine Drugs Price (USD/Pcs) by Application (2020-2031)
 Figure 63. Migraine Drugs Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Anti Migraine Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Migraine Drugs Market Research Report 2025
Global Cluster Headache Syndrome Drug Market Research Report 2025
Global CGT Drugs Market Research Report 2025
Prescription Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antidepressant Medication Market Research Report 2025
Global Medicines for Alzheimer Disease Treatment Market Research Report 2025
Cluster Headache Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Guidewire Market Research Report 2024
Antidepressants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Insomnia Pharmacological Treatment Market Research Report 2025
Global Drugs of Abuse Testing Market Research Report 2024
Global Treatment Planning Software Market Research Report 2025
Global Chemical Dosing Units Market Research Report 2025
Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmerging Market Research Report 2025
Pain Relief Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Absorbable Pain Relievers for External Use Market Research Report 2025
Global Drug Safety and Pharmacovigilance Service Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions